% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Div:299474,
author = {I. Divé$^*$ and L. Hahnefeld and K. J. Wenger$^*$ and D.
Kögel and J. Steinbach$^*$ and G. Geisslinger and M. W.
Ronellenfitsch$^*$ and I. Tegeder},
title = {{P}lasma lipidomic and metabolomic profiles in high-grade
glioma patients before and after 72-h presurgery water-only
fasting.},
journal = {Molecular oncology},
volume = {19},
number = {8},
issn = {1574-7891},
address = {Hoboken, NJ},
publisher = {John Wiley $\&$ Sons, Inc.},
reportid = {DKFZ-2025-00434},
pages = {2249-2269},
year = {2025},
note = {2025 Aug;19(8):2249-2269},
abstract = {Glioblastoma (GB) is the most aggressive primary brain
tumor with poor prognosis despite multimodal therapy.
Calorie-restricted diets have emerged as putative strategies
to augment anticancer therapies. We employed
UHPLC-high-resolution mass spectrometry analyses of plasma
lipids and polar metabolites to assess the systemic
metabolic effects of a 72-h preoperative fasting period in
IDH-wild-type glioma patients (n = 9 GB and n = 1 diffuse
pediatric-type high-grade H3/IDH-wildtype) who participated
in the prospective ERGO3 trial (NCT04461938). Fasting
reduced lysophosphatidylcholines (LPC, LPC-O),
lysophosphatidylethanolamines (LPE, LPE-O), and increased
free fatty acids and carnitines. Triglyceride (TG) profiles
shifted from short-chain TGs (42-48 C-atoms) to very
long-chain TGs (58-60 C-atoms) indicating an exploitation of
neutral lipid stores. Branched-chain amino acids,
aminobutyric acid, and uric acids were increased, and
glucose reduced after fasting. The effects of fasting were
comparable in men and women. To our knowledge, this is the
first study that evaluated the effects of fasting on
systemic lipid/metabolite levels in GB patients. Our results
may hold promise for integrating fasting interventions as a
component of a potential metabolic tumor therapy.},
keywords = {fasting (Other) / glioblastoma (Other) / lipidomic (Other)
/ lysophosphatidylcholines (Other) / metabolomic (Other) /
plasma (Other)},
cin = {FM01},
ddc = {610},
cid = {I:(DE-He78)FM01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:39992790},
doi = {DOI:10.1002/1878-0261.70003},
url = {https://inrepo02.dkfz.de/record/299474},
}